15 results
A quick infographic describing some of the common reversal agents used by anesthesiologists, their mechanism of
reversal #agents #management ... Dongare, P., &amp ... anaesthesia and critical ... Pharmacology of ... neuromuscular pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
PO once daily (AI ... PO or IV daily (AI ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
HIV-AIDS Preventing Clinical ... and preventing clinical ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
Infection General Management ... times weekly (AI ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
Intern Pocket Cards - Antibiogram and Susceptibilities
VRE - MRSA - GRAM POSITIVES - GRAM NEGATIVES -
ampicillin, amox-clav/amp-sulbactam ... (Use clinical data ... #antibiotics #management ... #pharmacology
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
Diagnosis: • LIP ... salivary ducts Clinical ... , UIP, NSIP): • ... lubricants • Pharmacologic ... Rheumatology #Diagnosis #Management
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
disease based on clinical ... 500 mg PO BID (AI ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
mg/kg IV daily (AII ... • Use until clinical ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
mg/kg IV daily (AI ... weeks or until clinically ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Cryptococcosis in HIV-AIDS
Treatment for cryptococcosis consists of 3 phases: induction,
mg/kg PO QID (AI ... as substantial clinical ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology